These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

933 related items for PubMed ID: 24824840

  • 1. Long-term follow-up for percutaneous transluminal angioplasty in renal artery fibromuscular dysplasia.
    Gavalas MV, Gasparis AP, Tassiopoulos AK, Loh S, Labropoulos N.
    Int Angiol; 2015 Dec; 34(6):529-37. PubMed ID: 24824840
    [Abstract] [Full Text] [Related]

  • 2. Short- and long-term outcomes of percutaneous transluminal angioplasty/stenting of renal fibromuscular dysplasia over a ten-year period.
    Mousa AY, Campbell JE, Stone PA, Broce M, Bates MC, AbuRahma AF.
    J Vasc Surg; 2012 Feb; 55(2):421-7. PubMed ID: 22112553
    [Abstract] [Full Text] [Related]

  • 3. Revascularisation of renal artery stenosis caused by fibromuscular dysplasia: effects on blood pressure during 7-year follow-up are influenced by duration of hypertension and branch artery stenosis.
    Alhadad A, Mattiasson I, Ivancev K, Gottsäter A, Lindblad B.
    J Hum Hypertens; 2005 Oct; 19(10):761-7. PubMed ID: 15920452
    [Abstract] [Full Text] [Related]

  • 4. [The long-term results on arterial pressure and kidney function after the percutaneous transluminal dilatation of renal artery stenosis].
    Rodríguez Pérez JC, Maynar Moliner M, Pérez Borges P, Plaza Toledano C, Reyes Pérez R, Pulido Duque JM, Palop Cubillo L, Rodríguez Pérez A.
    Med Clin (Barc); 1997 Mar 15; 108(10):366-72. PubMed ID: 9139142
    [Abstract] [Full Text] [Related]

  • 5. Percutaneous transluminal angioplasty with selective stenting for the treatment of renal artery stenosis caused by fibromuscular dysplasia: 18 years' experience from the China Center for Cardiovascular Disease.
    Chen Y, Dong H, Jiang X, Deng Y, Zou Y, Che W, Xiong H, Xu B, Yang Y, Gao R.
    Catheter Cardiovasc Interv; 2020 Feb 15; 95 Suppl 1():641-647. PubMed ID: 31943685
    [Abstract] [Full Text] [Related]

  • 6. The long-term outcomes of percutaneous therapy for renal artery fibromuscular dysplasia.
    Davies MG, Saad WE, Peden EK, Mohiuddin IT, Naoum JJ, Lumsden AB.
    J Vasc Surg; 2008 Oct 15; 48(4):865-71. PubMed ID: 18692345
    [Abstract] [Full Text] [Related]

  • 7. Insights from intravascular pressure measurement of renal artery revascularization in patients with fibromuscular dysplasia: The DYSART study.
    Cadour F, Silhol F, Iline N, Giorgi R, Lorthioir A, Amar L, Sapoval M, Rousseau H, Sarlon G, Thony F, Jacquier A.
    J Vasc Surg; 2022 Mar 15; 75(3):939-949.e1. PubMed ID: 34601043
    [Abstract] [Full Text] [Related]

  • 8. Incidence and risk factors for restenosis, and its impact on blood pressure control after percutaneous transluminal renal angioplasty in hypertensive patients with renal artery stenosis.
    Iwashima Y, Fukuda T, Yoshihara F, Kusunoki H, Kishida M, Hayashi S, Nakamura S, Kamide K, Horio T, Kawano Y.
    J Hypertens; 2016 Jul 15; 34(7):1407-15. PubMed ID: 27065003
    [Abstract] [Full Text] [Related]

  • 9. Clinical and duplex ultrasound follow-up after balloon angioplasty for atherosclerotic renal artery stenosis.
    Morellato C, Bergelin RO, Cantwell-Gab K, Zierler RE, Polissar NL, Davidson RC, Strandness DE.
    Vasc Surg; 2001 Jul 15; 35(2):85-93. PubMed ID: 11668375
    [Abstract] [Full Text] [Related]

  • 10. Effects of Percutaneous Transluminal Renal Angioplasty on Office and Home Blood Pressure and Home Blood Pressure Variability in Hypertensive Patients With Renal Artery Stenosis.
    Iwashima Y, Fukuda T, Kusunoki H, Hayashi SI, Kishida M, Yoshihara F, Nakamura S, Kamide K, Horio T, Kawano Y.
    Hypertension; 2017 Jan 15; 69(1):109-117. PubMed ID: 27872233
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Treatment of renal artery fibromuscular dysplasia with balloon angioplasty: a prospective follow-up study.
    Birrer M, Do DD, Mahler F, Triller J, Baumgartner I.
    Eur J Vasc Endovasc Surg; 2002 Feb 15; 23(2):146-52. PubMed ID: 11863332
    [Abstract] [Full Text] [Related]

  • 15. Clinical characteristics and treatment of renal artery fibromuscular dysplasia with percutaneous transluminal angioplasty: a long-term follow-up study.
    Yang YK, Zhang Y, Meng X, Yang KQ, Jiang XJ, Wu HY, Zhang HM, Song L, Wang LP, Gao LG, Zhou XL.
    Clin Res Cardiol; 2016 Nov 15; 105(11):930-937. PubMed ID: 27270759
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Percutaneous transluminal angioplasty improves blood pressure and renal function in renovascular hypertension.
    Bell GM, Reid J, Buist TA.
    Q J Med; 1987 May 15; 63(241):393-403. PubMed ID: 2958895
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Transplant renal artery stenosis: outcome after percutaneous intervention.
    Beecroft JR, Rajan DK, Clark TW, Robinette M, Stavropoulos SW.
    J Vasc Interv Radiol; 2004 Dec 15; 15(12):1407-13. PubMed ID: 15590798
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 47.